Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Weekly FDA Drug Pipeline Calendar (Feb 13 - Feb 17)

avatar
BioPharm Insight US wrote a column · Feb 13, 2023 10:12
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Next week big pharma companies such as $Biogen(BIIB.US)$ , $Sage Therapeutics(SAGE.US)$ , andIronwood $Ironwood Pharmaceuticals(IRWD.US)$ will release their quarterly earnings report.
BIGGEST MOVERS FROM THIS WEEK
$Hillstream BioPharma(HILS.US)$ shares continued to trade up this week after it announced initial results from a study conducted of HSB-1216 with pembrolizumab in KRAS G12C-mutated non-small cell lung cancer cells, calu-1. Data reported significantly greater tumor inhibition. Shares closed the week up 33% at $1.59.
$Sintx Technologies(SINT.US)$ announced a stock offering of 2,150,000 units this week, each with one Class C and D warrant. The units were priced at $5.60 each, with a gross profit of $12 million expected. The stock finished the week down 69% at $2.72.
$Revelation Biosciences(REVB.US)$ reported pre-clinical data of REVTx-300 in a model of acute and chronic kidney disease. The data showed that there was a significant reduction in circulating transforming growth factor- in a dose-dependent manner when compared to the positive control group. The public offering of 3,225,000 shares of stock and warrants was priced at $4.83 per unit. The total gross proceeds are expected to be around $15.6 million. The stock finished the week down 67% at $2.85.
$Omeros(OMER.US)$ received a milestone payment this week of $200 million from Rayner Surgical under the 2021 Asset Purchase Agreement. Shares closed the week up 23% at $5.05
EVENTS TO WATCH
Monday, February 13, 2023
NY Fed 1&5-year inflation expectations 11 am ET
Tuesday, February 14, 2023
January Consumer Price Index (CPI) 8:30 am ET
Discussion with Chair Jerome H. Powell at the Economic Club 12:40 pm ET
Wednesday, February 15, 2023
Initial Public Offering (IPO) ALPX
Thursday, February 16, 2023
Feb 4th Jobless Claims 8:30 am ET
ASCO Genitourinary Cancers Symposium
Weekly FDA Drug Pipeline Calendar (Feb 13 - Feb 17)
Source: BioPharmCatalyst, Benzinga
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
7
+0
3
Translate
Report
33K Views
Comment
Sign in to post a comment
We are the content provider of Moomoo Courses.
909Followers
8Following
1458Visitors
Follow